EVOLVA HOLDING SA INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS
30 JUNE 2021
Consolidated Statement of Financial Performance
CHF 1,000 | Note | Period from 1 January to 30 June | ||
2021 | 2020 | |||
Revenue from contracts with customers | 3 | 6'375.5 | 3'963.7 | |
Cost of goods sold | 4 | (12'678.6) | (4'149.1) | |
Gross profit | (6'303.1) | (185.4) | ||
Research & development expenses | 5 | (16'199.4) | (7'655.7) | |
Commercial, general & administrative expenses | 6 | (4'487.2) | (4'770.3) | |
Total operating expenses | (20'686.6) | (12'426.0) | ||
Operating loss | (26'989.7) | (12'611.4) | ||
Financial income | 7 | 3'510.1 | 452.7 | |
Financial expenses | 7 | (2'035.9) | (1'377.4) | |
Net loss before tax | (25'515.5) | (13'536.1) | ||
Income tax | 141.1 | 19.8 | ||
Net loss for the period | (25'374.4) | (13'516.3) | ||
Basic and diluted loss per share (in CHF) | (0.03) | (0.02) |
Consolidated Statement of Comprehensive Income
CHF 1,000 | Note | Period from 1 January to 30 June | |
2021 | 2020 | ||
Net loss for the period | - | (25'374.4) | (13'516.3) |
Items may be reclassified to statement of financial performance | |||
(net of tax) | |||
- Translation differences | - | 1'794.4 | (995.0) |
Items not to be reclassified to statement of financial | |||
performance (net of tax) | |||
- Remeasurement gain/(loss) on defined benefit plans | - | 1'055.5 | 28.4 |
Other comprehensive loss (net of tax) | 2'850.0 | (966.6) | |
Total comprehensive loss | (22'524.5) | (14'482.9) |
Page 1 of 16
Consolidated Statement of Financial Position
CHF 1,000 | Note | 30 June 2021 31 December 2020 | |
ASSETS | |||
Non-current assets | |||
Intangible assets | 8 | 116'416.6 | 123'894.1 |
Property, plant and equipment | - | 6'569.8 | 6'914.2 |
Financial assets | 11 | 3'379.0 | 2'507.8 |
Total non-current assets | 126'365.4 | 133'316.1 | |
Current assets | |||
Inventories | 10 | 9'881.8 | 9'125.3 |
Prepayments & deferred income | - | 2'194.5 | 2'434.8 |
Trade and other receivables | - | 4'559.1 | 2'347.3 |
Cash and cash equivalents | - | 13'129.0 | 19'669.4 |
Total current assets | 29'764.3 | 33'576.8 | |
Total Assets | 156'129.7 | 166'892.9 | |
EQUITY AND LIABILITIES | |||
Equity | |||
Share capital | 12 | 46'343.9 | 41'093.9 |
Share premium | - | 355'913.9 | 355'082.6 |
Treasury shares | 13 | (4'142.0) | (3'709.2) |
Other reserves | - | 38'970.9 | 39'233.0 |
Accumulated loss | - | (311'766.0) | (286'391.6) |
Other components of equity | - | 2'633.4 | (216.6) |
Total equity | 127'954.2 | 145'092.1 | |
Non-current liabilities | |||
Deferred tax liabilities | - | - | 132.8 |
Pension liabilities | - | 1'497.5 | 2'350.7 |
Lease liabilities | - | 3'806.2 | 4'178.5 |
Provisions | 14 | 506.8 | - |
Total non-current liabilities | 5'810.6 | 6'662.1 | |
Current liabilities | |||
Trade payables | - | 3'567.7 | 2'128.3 |
Provisions and accrued liabilities | 14 | 7'786.6 | 7'951.6 |
Convertible loan | 15 | 9'538.8 | 3'785.8 |
Compound embedded derivative | 15 | 461.2 | 214.2 |
Lease liabilities | - | 1'010.6 | 1'058.8 |
Total current liabilities | 22'364.9 | 15'138.7 | |
Total Equity and Liabilities | 156'129.7 | 166'892.9 |
Page 2 of 16
Consolidated Statement of Cash Flow
CHF 1,000 | Note | Period from 1 January to 30 June | |
2021 | 2020 | ||
Operating activities | |||
Net loss for the period | - | (25'374.4) | (13'516.3) |
Non-cash adjustments to reconcile net loss for the | |||
period to net cash flows | |||
- Depreciation of tangible assets | - | 667.4 | 842.5 |
- Amortisation of intangible assets | 8 | 3'663.7 | 3'465.8 |
- Impairment of patents and patent application | 8 | 9'628.4 | - |
- Interest income | 7 | (101.8 ) | - |
- Financial expenses | 7 | 639.3 | 311.4 |
- Net foreign exchange differences | 7 | (1'954.0) | 788.7 |
- Share-based compensation | 9 | 114.9 | 661.7 |
- Changes in deferred tax liability | - | (141.1) | - |
- Change in current assets | - | (2'367.0) | (4'347.6) |
- Change in current liability | - | 857.0 | (1'027.1) |
- Change in provisions | - | 710.0 | 646.2 |
- Change in pension liabilities | - | 202.3 | 88.1 |
- Interest payments received | - | 101.8 | - |
- Interest expenses paid | - | (179.3) | (311.4) |
Net cash flow from operating activities | (13'532.8) | (12'398.1) | |
Investing activities | |||
Purchase of property, plant and equipment | - | (324.9) | (703.6) |
Disposal of property, plant & equipment | - | 4.0 | - |
Capitalised development expenses 1) | 8 | (2'503.0) | (878.1) |
Financial loans | 11 | (1'941.5) | - |
Withdrawal of financial deposit | 11 | 1'074.8 | (3.5 ) |
Cash flow from investing activities | (3'690.7) | (1'585.2) | |
Financing activities | |||
Proceeds from convertible loan | 15 | 11'040.0 | - |
Cost of capital change | - | - | (98.6) |
Payment of principal portion of lease liabilities | - | (422.0) | (520.7) |
Cash flow from financing activities | 10'618.1 | (619.3) | |
Net decrease in cash and cash equivalents | (6'540.3) | (14'602.5) | |
Exchange gain/(loss) on cash and cash equivalents | - | 65.1 | (34.3) |
Cash and cash equivalents, beginning of period | - | 19'669.4 | 39'919.8 |
Cash and cash equivalents, end of period | 13'129.0 | 25'283.0 |
- Capitalized development expenses in 2020 have been reclassified to cash flow from investing activities from cash flow from operating activities. In 2020, cash flow from operating activities was TCHF (13,276.1) and cash flow from investing activities was TCHF (707.1). The net change in cash and cash equivalents remains unchanged.
Page 3 of 16
Consolidated Statement of Equity
Total | Cumulative | |||||||||
Share | Share | capital | Treasury | Other | Employee | translation | Accumulated | |||
CHF 1,000 | Note | Capital | premium | paid in | shares | Reserves | benefit reserve | differences | loss | Total Equity |
At 1 January 2020 | 159'375.6 | 230'834.0 | 390'209.6 | (4'345.8) | 39'081.3 | (1'002.1) | 5'140.3 | (256'521.3) | 172'562.1 | |
Loss for the period | - | - | - | - | - | - | - | - | (13'516.3) | (13'516.3) |
Other comprehensive income | - | - | - | - | - | - | 28.4 | (995.0) | - | (966.6) |
Total comprehensive loss | - | - | - | - | - | - | 28.4 | (995.0) | (13'516.3) | (14'482.9) |
Share capital increase | - | - | - | - | - | - | - | - | - | |
Capital increase from issuance of | 12 | 5'000.0 | 2'050.0 | 7'050.0 | (7'050.0) | - | - | - | - | - |
treasury shares | ||||||||||
Nominal value reduction | 12 | (123'281.7) | 123'281.7 | - | - | - | - | - | - | - |
Cost of capital change | - | - | (98.6) | (98.6) | - | - | - | - | - | (98.6) |
Effects of share based compensation | 9 | - | - | - | - | 661.7 | - | - | - | 661.7 |
Vesting of shares for share-based | 9 | - | - | - | 635.6 | (671.8) | - | - | 36.2 | - |
compensation | ||||||||||
Balance at 30 June 2020 | 41'093.9 | 356'067.1 | 397'161.0 | (10'760.2) | 39'071.1 | (973.7) | 4'145.3 | (270'001.4) | 158'642.1 | |
At 1 January 2021 | 41'093.9 | 355'082.6 | 396'176.5 | (3'709.2) | 39'233.0 | (940.5) | 723.9 | (286'391.6) | 145'092.1 | |
Loss for the period | - | - | - | - | - | - | - | - | (25'374.4) | (25'374.4) |
Other comprehensive income | - | - | - | - | - | - | 1'055.5 | 1'794.4 | - | 2'850.0 |
Total comprehensive loss | - | - | - | - | - | - | 1'055.5 | 1'794.4 | (25'374.4) | (22'524.5) |
Capital increase from issuance of | 12 | 5'250.0 | - | 5'250.0 | (5'250.0) | - | - | - | - | - |
treasury shares | ||||||||||
Cost of capital change | - | - | (228.4) | (228.4) | - | - | - | - | - | (228.4) |
Vesting of shares for share-based | 9 | - | - | - | 377.0 | (425.6) | - | - | - | 114.9 |
compensation | ||||||||||
Effects of share based compensation | 9 | - | 163.5 | |||||||
Conversion of convertible loan | - | 1'059.7 | 1'059.7 | 4'440.3 | - | - | - | - | 5'500.0 | |
Balance at 30 June 2021 | 46'343.9 | 355'913.9 | 402'257.9 | (4'142.0) | 38'970.9 | 115.0 | 2'518.3 | (311'766.0) | 127'954.2 |
Page 4 of 16
Attachments
- Original document
- Permalink
Disclaimer
Evolva Holding SA published this content on 26 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 August 2021 08:10:07 UTC.
